JP2022553083A5 - - Google Patents
Info
- Publication number
- JP2022553083A5 JP2022553083A5 JP2022523915A JP2022523915A JP2022553083A5 JP 2022553083 A5 JP2022553083 A5 JP 2022553083A5 JP 2022523915 A JP2022523915 A JP 2022523915A JP 2022523915 A JP2022523915 A JP 2022523915A JP 2022553083 A5 JP2022553083 A5 JP 2022553083A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- composition
- sequence
- vector
- inh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025055764A JP2025098221A (ja) | 2019-10-23 | 2025-03-28 | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924877P | 2019-10-23 | 2019-10-23 | |
| US62/924,877 | 2019-10-23 | ||
| PCT/US2020/056984 WO2021081280A1 (en) | 2019-10-23 | 2020-10-23 | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025055764A Division JP2025098221A (ja) | 2019-10-23 | 2025-03-28 | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553083A JP2022553083A (ja) | 2022-12-21 |
| JP2022553083A5 true JP2022553083A5 (cg-RX-API-DMAC7.html) | 2023-10-30 |
| JP7659550B2 JP7659550B2 (ja) | 2025-04-09 |
Family
ID=73498274
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523915A Active JP7659550B2 (ja) | 2019-10-23 | 2020-10-23 | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 |
| JP2025055764A Ceased JP2025098221A (ja) | 2019-10-23 | 2025-03-28 | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025055764A Ceased JP2025098221A (ja) | 2019-10-23 | 2025-03-28 | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230043051A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048800A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7659550B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115176022A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021081280A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230340078A1 (en) * | 2019-11-14 | 2023-10-26 | Biomarin Pharmaceutical Inc. | Treatment of hereditary angioedema with liver-specific gene therapy vectors |
| EP4263614A1 (en) * | 2020-12-16 | 2023-10-25 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| KR20230136147A (ko) * | 2021-01-27 | 2023-09-26 | 스파크 테라퓨틱스, 인코포레이티드 | 유전성 혈관부종을 치료하기 위한 조성물 및 방법 |
| TW202332472A (zh) * | 2021-10-01 | 2023-08-16 | 美商拜奧馬林製藥公司 | 利用aav基因療法載體進行之遺傳性血管水腫治療及治療性調配物 |
| CN117947040A (zh) | 2022-10-31 | 2024-04-30 | 苏州荷光科汇生物科技有限公司 | 用于目的基因的表达盒及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136597A (en) | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
| US7419829B2 (en) | 2000-10-06 | 2008-09-02 | Oxford Biomedica (Uk) Limited | Vector system |
| US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
| CA2462628C (en) | 2001-10-02 | 2019-08-20 | Institut Clayton De La Recherche | Restricted expression lentiviral vectors |
| EP1737966B1 (en) | 2004-04-02 | 2012-05-09 | Board of Regents, The University of Texas System | Cancer specific promoters |
| US9617548B2 (en) | 2008-04-22 | 2017-04-11 | Vib Vzw | Liver-specific nucleic acid regulatory elements and methods and use thereof |
| JP6091435B2 (ja) | 2011-02-22 | 2017-03-08 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達 |
| GB201206455D0 (en) | 2012-04-12 | 2012-05-30 | Royal Holloway & Bedford New College | Gene expression |
| DK2911687T3 (da) | 2012-10-26 | 2019-05-13 | Univ Brussel Vrije | Vektor til levermålrettet genterapi af hæmofili og fremgangsmåder og anvendelse deraf |
| WO2014063753A1 (en) | 2012-10-26 | 2014-05-01 | Vrije Universiteit Brussel | Hyper-active factor ix vectors for liver-directed gene therapy of hemophilia 'b' and methods and use thereof |
| AU2014228765A1 (en) | 2013-03-15 | 2015-10-15 | Medimmune, Llc | Palivizumab epitope-based virus-like particles |
| JP6754361B2 (ja) | 2014-12-16 | 2020-09-09 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ | 若年型バッテン病のための遺伝子療法 |
| CL2014003590A1 (es) | 2014-12-30 | 2015-07-10 | Univ Chile | Virus aav/xbp1s-ha, método de tratamiento genético y su uso en la optimizacion y mejoramiento de las capacidades cognitivas, de memoria y de aprendizaje. |
| MA41346A (fr) | 2015-01-12 | 2017-11-21 | Juno Therapeutics Inc | Eléments régulateurs post-transcriptionnels d'hépatite modifiée |
| JP6879486B2 (ja) * | 2015-03-17 | 2021-06-02 | フリーイェ・ユニヴェルシテイト・ブリュッセルVrije Universieit Brussel | Fviiiおよびfix用の最適化された肝臓特異的発現系 |
| US10179918B2 (en) | 2015-05-07 | 2019-01-15 | Sangamo Therapeutics, Inc. | Methods and compositions for increasing transgene activity |
| CN113999875A (zh) * | 2015-05-28 | 2022-02-01 | 康奈尔大学 | 腺相关病毒介导的c1ei递送作为用于血管性水肿的疗法 |
| KR20180014051A (ko) * | 2015-05-28 | 2018-02-07 | 코넬 유니버시티 | 혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달 |
| GB2547179A (en) | 2015-10-26 | 2017-08-16 | Quethera Ltd | Genetic construct |
| US10190135B2 (en) | 2015-10-27 | 2019-01-29 | Celltheon Corporation | Chimeric post-transcriptional regulatory element |
| CN108463243B (zh) * | 2015-11-19 | 2022-06-14 | 夏尔人类遗传性治疗公司 | 重组人c1酯酶抑制剂及其用途 |
| WO2017139381A1 (en) * | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
| AU2017248259A1 (en) | 2016-04-07 | 2018-10-25 | Bluebird Bio, Inc. | Chimeric antigen receptor T cell compositions |
| CN109844124B (zh) | 2016-05-20 | 2023-10-03 | 哈佛学院董事及会员团体 | 年龄相关疾病和病症的基因治疗方法 |
| ES3024357T3 (en) | 2017-02-17 | 2025-06-04 | Purdue Research Foundation | Targeted ligand-payload based drug delivery for cell therapy |
| EP3740581A4 (en) * | 2018-01-16 | 2021-10-27 | CLS Therapeutics Limited | TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY |
-
2020
- 2020-10-23 WO PCT/US2020/056984 patent/WO2021081280A1/en not_active Ceased
- 2020-10-23 EP EP20811148.4A patent/EP4048800A1/en not_active Withdrawn
- 2020-10-23 JP JP2022523915A patent/JP7659550B2/ja active Active
- 2020-10-23 CN CN202080084617.XA patent/CN115176022A/zh active Pending
- 2020-10-23 US US17/771,275 patent/US20230043051A1/en not_active Abandoned
-
2025
- 2025-03-28 JP JP2025055764A patent/JP2025098221A/ja not_active Ceased